1. Home
  2. GIS vs RPRX Comparison

GIS vs RPRX Comparison

Compare GIS & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo General Mills Inc.

GIS

General Mills Inc.

HOLD

Current Price

$31.94

Market Cap

18.5B

ML Signal

HOLD

Logo Royalty Pharma plc

RPRX

Royalty Pharma plc

HOLD

Current Price

$55.10

Market Cap

22.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GIS
RPRX
Founded
1866
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.5B
22.0B
IPO Year
2003
2020

Fundamental Metrics

Financial Performance
Metric
GIS
RPRX
Price
$31.94
$55.10
Analyst Decision
Hold
Strong Buy
Analyst Count
16
5
Target Price
$42.07
$51.40
AVG Volume (30 Days)
9.4M
3.2M
Earning Date
03-18-2026
05-06-2026
Dividend Yield
7.08%
1.90%
EPS Growth
N/A
N/A
EPS
3.56
0.67
Revenue
$2,037,800,000.00
$2,378,193,000.00
Revenue This Year
N/A
$38.63
Revenue Next Year
N/A
$4.73
P/E Ratio
$9.04
$82.04
Revenue Growth
4.11
5.06
52 Week Low
$31.85
$33.37
52 Week High
$55.19
$55.86

Technical Indicators

Market Signals
Indicator
GIS
RPRX
Relative Strength Index (RSI) 30.30 65.49
Support Level N/A $35.35
Resistance Level $34.62 N/A
Average True Range (ATR) 0.88 1.14
MACD -0.01 0.04
Stochastic Oscillator 0.54 83.21

Price Performance

Historical Comparison
GIS
RPRX

About GIS General Mills Inc.

General Mills is a global packaged-food company that produces snacks, cereal, convenient meals, dough, baking mixes and ingredients, pet food, and superpremium ice cream. Its largest brands are Nature Valley, Cheerios, Old El Paso, Pillsbury, Betty Crocker, Blue Buffalo, and Haagen-Dazs. In fiscal 2025, 81% of its revenue was derived from the United States, although the company also operates in Canada, Europe, Australia, Asia, and Latin America. Although most of General Mills' products are sold through retail stores to consumers, the company also sells products to the foodservice channel and the commercial baking industry.

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

Share on Social Networks: